Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt

Simple item page
buir.contributor.authorÇatalak Yılmaz, Hazal Beril
buir.contributor.authorSulaiman, Mahnoor
buir.contributor.authorIşık, Özlem Aybüke
buir.contributor.authorÇizmecioğlu, Onur
buir.contributor.orcidHazal Beril Çatalak Yılmaz|0000-0003-3059-093X
buir.contributor.orcidMahnoor Sulaiman|0000-0002-5146-2761
buir.contributor.orcidÖzlem Aybüke Işık|0000-0002-8357-889X
buir.contributor.orcidOnur Çizmecioğlu|0000-0002-7608-6950
dc.citation.epage10en_US
dc.citation.spage1
dc.citation.volumeNumberEarly Access
dc.contributor.authorÇatalak Yılmaz, Hazal Beril
dc.contributor.authorSulaiman, Mahnoor
dc.contributor.authorIşık, Özlem Aybüke
dc.contributor.authorÇizmecioğlu, Onur
dc.date.accessioned2024-03-14T06:40:44Z
dc.date.available2024-03-14T06:40:44Z
dc.date.issued2023-12-20
dc.departmentDepartment of Molecular Biology and Genetics
dc.description.abstractObjectives The catalytic subunits of Class IA PI3K, p110 alpha, p110 beta, and p110 delta, phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) into phosphatidylinositol 3,4,5-trisphosphate (PIP3) on the plasma membrane. In cancer, these catalytic subunits are usually found to be altered or amplified. Because pan-PI3K inhibition results in systemic toxicities, finding specific targets for the ubiquitous PI3K isoforms offers considerable potential for enhancing the effectiveness of PI3K-targeted therapy. Methods We aim to delineate the isoform-specific druggable targets of the PI3K by deleting PIK3CA (encoding p110 alpha) and PIK3CB (encoding p110 beta) by Cre mediated excision and ectopically expressing p110 alpha, p110 beta, or p110 delta with or without myristoylation (Myr) tag in mouse embryonic fibroblasts (MEFs). Myr is a lipidation signal that translocates proteins to plasma membrane permanently. This translocation renders p110s constitutively activated as they remain in close proximity to PIP(2 )on the membrane. Results Unique and redundant Akt targets are identified downstream of different PI3K isoforms. mTORC1, one of the targets of fully-activated Akt, has been observed to be differentially regulated in MEFs upon expression of p110 alpha or p110 beta. The varying dependencies on mTORC1 and Rac1 led us to analyse a potential scaffolding function of p110 beta with Rac1 to mediate phosphorylation and activation of mTOR using platforms for the modeling of biomolecular complexes. We also documented that p110 alpha and p110 beta support cell cycle kinetics differentially. Conclusions This study suggests differential regulation of protein translation, metabolism, cell cycle, and survival signaling downstream of unique p110 targets, underlying the importance of cancer treatment according to the deregulated p110 isoform.
dc.identifier.doi10.1515/tjb-2023-0146
dc.identifier.issn0250-4685
dc.identifier.urihttps://hdl.handle.net/11693/114714
dc.language.isoen
dc.publisherWalter De Gruyter GMBH
dc.relation.isversionofhttps://dx.doi.org/10.1515/tjb-2023-0146
dc.source.titleTurkish Journal of Biochemistry - Türk Biyokimya Dergisi
dc.subjectPhosphoinositide 3-kinase
dc.subjectProtein kinase B
dc.subjectMammalian target of rapamycin (mTOR)
dc.subjectCell cycle
dc.subjectCytotoxicity
dc.titleClass IA PI3K isoforms lead to differential signalling downstream of PKB/Akt
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Class_IA_PI3K_isoforms_lead_to_differential_signalling_downstream_of_PKBAkt.pdf
Size:
2.4 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.01 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Molecular Biology and Genetics